Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study ; volume:22 ; number:1 ; day:18 ; month:7 ; year:2022 ; pages:1-13 ; date:12.2022
BMC cancer ; 22, Heft 1 (18.7.2022), 1-13, 12.2022
- Creator
-
Li, Anchuan
Huang, Tingxuan
Zheng, Rong
Chi, Pan
Li, Zhihua
Wang, Xiaozhong
Xu, Benhua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-09855-z
- URN
-
urn:nbn:de:101:1-2022092801081539187711
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
02.03.2026, 7:16 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Anchuan
- Huang, Tingxuan
- Zheng, Rong
- Chi, Pan
- Li, Zhihua
- Wang, Xiaozhong
- Xu, Benhua
- SpringerLink (Online service)
Other Objects (12)
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
Capecitabine-Associated Terminal Ileitis
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
Photosensitive lichenoid skin reaction to capecitabine
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
Capecitabine-Associated Terminal Ileitis
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
Photosensitive lichenoid skin reaction to capecitabine
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
Capecitabine-Associated Terminal Ileitis
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
Photosensitive lichenoid skin reaction to capecitabine
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines